tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

ACHL Stock Latest News

Achilles Therapeutics Shifts Strategy, Seeks Alternatives
Company AnnouncementsAchilles Therapeutics Shifts Strategy, Seeks Alternatives
2d ago
6K
ACHL
Achilles to end development of TIL-based cNeT therapy, conduct strategic review
PremiumThe Fly
Achilles to end development of TIL-based cNeT therapy, conduct strategic review
2d ago
ACHL
Achilles Therapeutics Announces Strategic Update
PremiumPress Releases
Achilles Therapeutics Announces Strategic Update
2d ago
ACHL
Achilles Therapeutics Excels in Q2 with Promising Trials
PremiumCompany Announcements
Achilles Therapeutics Excels in Q2 with Promising Trials
1M ago
6K
ACHL
Achilles Therapeutics reports Q2 EPS (41c) vs (42c) last year
PremiumThe Fly
Achilles Therapeutics reports Q2 EPS (41c) vs (42c) last year
1M ago
ACHL
Achilles Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Updates
PremiumPress ReleasesAchilles Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Updates
1M ago
ACHL
Leadership Shift at Achilles Therapeutics
Premium
Company Announcements
Leadership Shift at Achilles Therapeutics
2M ago
6K
ACHL
Achilles Therapeutics AGM Concludes with Key Approvals
Premium
Company Announcements
Achilles Therapeutics AGM Concludes with Key Approvals
3M ago
6K
ACHL
Achilles Therapeutics Calls for AGM Participation
PremiumCompany Announcements
Achilles Therapeutics Calls for AGM Participation
4M ago
6K
ACHL
Achilles Therapeutics announces research collaboration with Arcturus
PremiumThe Fly
Achilles Therapeutics announces research collaboration with Arcturus
4M ago
ACHL
ARCT
Achilles Therapeutics Announces Research Collaboration with Arcturus Therapeutics to Explore Second-Generation Personalized mRNA Cancer Vaccines
PremiumPress Releases
Achilles Therapeutics Announces Research Collaboration with Arcturus Therapeutics to Explore Second-Generation Personalized mRNA Cancer Vaccines
4M ago
ACHL
Achilles Therapeutics Addresses Nasdaq Notice
PremiumCompany Announcements
Achilles Therapeutics Addresses Nasdaq Notice
4M ago
6K
ACHL
Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
PremiumPress ReleasesAchilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
4M ago
ACHL
Achilles Therapeutics: Promising Q1 2024 Results
Premium
Company Announcements
Achilles Therapeutics: Promising Q1 2024 Results
5M ago
6K
ACHL
Achilles Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
Premium
Press Releases
Achilles Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
5M ago
ACHL
Achilles Therapeutics reports Q1 EPS (30c), consensus (46c)
PremiumThe Fly
Achilles Therapeutics reports Q1 EPS (30c), consensus (46c)
5M ago
ACHL
Piper downgardes Achilles Therapeutics, says ‘step-function’ change needed
PremiumThe Fly
Piper downgardes Achilles Therapeutics, says ‘step-function’ change needed
6M ago
ACHL
Achilles Therapeutics price target lowered to $6 from $11 at Chardan
PremiumThe Fly
Achilles Therapeutics price target lowered to $6 from $11 at Chardan
6M ago
ACHL
Achilles Therapeutics downgraded to Neutral from Overweight at Piper Sandler
PremiumThe Fly
Achilles Therapeutics downgraded to Neutral from Overweight at Piper Sandler
6M ago
ACHL
Achilles Therapeutics reports Q4 EPS (46c) vs. (61c) last year
PremiumThe FlyAchilles Therapeutics reports Q4 EPS (46c) vs. (61c) last year
6M ago
ACHL
Achilles Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Recent Business Highlights
Premium
Press Releases
Achilles Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Recent Business Highlights
6M ago
ACHL
Achilles Therapeutics provides update on Phase I/IIa NSCLC results
Premium
The Fly
Achilles Therapeutics provides update on Phase I/IIa NSCLC results
6M ago
ACHL

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >